Interessi Passivi Sul Debito Cambiamento Data
Adma Biologics USD 3.42M 1.32M 2026-06
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Cytokinetics USD 38.48M 3.65M 2026-09
Gilead Sciences USD 269M 22M 2026-09
Heron Therapeutics USD 600K 100K 2024-12
Immunic 197K 222K 2025-12
Insmed USD 20.41M 1.57M 2026-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
MacroGenics USD 4.4M 493K 2026-06
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 112.4M 108.78M 2026-09
Pfizer USD 662M 5M 2026-09
Rockwell Medical USD 232K 199K 2024-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
United Therapeutics USD 2.9M 0 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09